(ALKS:Consolidated Issue Listed on NASDAQ Global Select )
Elliot W. Ehrich M.D.
Chief Medical Officer and Executive Vice President of Research and Development,Alkermes plc
|Age||Total Calculated Compensation||This person is connected to 22 board members in 2 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Elliot W. Ehrich, M.D. serves as the Executive Vice President of Research and Development since February 2015 and Chief Medical Officer of Alkermes plc (also known as Alkermes Inc) since September 2011 and he served as Senior Vice President of Research & Development since May 22, 2007. Dr. Ehrich serves as a Member of Advisory Board of Epernicus LLC. He serves as a Member of Scientific Advisory Board of Aileron Therapeutics, Inc. Dr. Ehrich served as the Vice President ...
Connaught HousePhone: 353 1 772 8000
Dublin, Co. Dublin 4
Board Members Memberships*There is no Board Members Memberships data available.
Columbia University College of Physicians & Surgeons in New York
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|